
Maternal and Child Health Library
MCH Alert: Focus on Infant Mortality is developed by the Maternal
and Child Health Library in collaboration with the National Sudden
and Unexpected Infant/Child and Pregnancy Loss Resource Center at
Georgetown University. This
and past issues are available online
at http://www.mchlibrary.info/alert/archives.html and http://www.sidscenter.org/alert/archives.html.
June 25, 2010
Multimedia Featured Resource: History, Highlights and Hope:
Shattering the U.S. Infant Mortality Glass Ceiling was held on June 17,
2010. The Webinar was co-produced by the National Association of County
and City Health Officials and CityMatCH as part of the Emerging Issues
in Maternal and Child Health (MCH) series, with support from the Health
Resources and Services Administration's Maternal and Child Health
Bureau and the Centers for Disease Control and Prevention's National
Center on Birth Defects and Developmental Disabilities Prevention.
Topics included the history of U.S. efforts to reduce infant mortality;
advances and successes in reducing infant mortality; current and
emerging science, research, and vision for the future; and the role of
local health departments and other community organizations in infant
mortality reduction programs. The Webinar archive (presenter
information, recording, and materials) is available at https://cc.readytalk.com/cc/schedule/display.do?udc=o7kewuje4j81
1. Article Examines African-American Mothers' Beliefs and
Perceptions About SIDS
2. Study Explores the Impact of Miscarriage History on
Prenatal Distress During a Subsequent Pregnancy
3. Authors Analyze Percentage of Infant Morbidity and
Mortality Attributable to Prenatal Smoking
4. Research Investigates Association Between Exposure to
Valproic Acid in Pregnancy and Risk of Major Congenital Malformation
************************************************************
1. ARTICLE EXAMINES AFRICAN-AMERICAN MOTHERS' BELIEFS AND
PERCEPTIONS ABOUT SIDS
"Our findings that the African-American mothers in our cohort perceive
the link between risk factors and SIDS [sudden infant death syndrome]
to be implausible, SIDS to be a random, unpreventable occurrence, and
parental vigilance to be the key to SIDS prevention build on findings
of earlier studies," write the authors of an article published in the
July 2010 issue of the Journal of Pediatrics. Despite the 50 percent
decline in the incidence of SIDS in the United States since the first
American Academy of Pediatrics recommendations for infant sleep in
1992, African-American infants remain twice as likely to die from SIDS
as white infants. To better understand parental decisions and because
of the racial disparity seen in both SIDS rates and SIDS-reduction
behaviors, the authors of this article conducted a qualitative study of
African-American parents using focus group interviews and individual
in-depth semi-structured interviews to examine parental beliefs and
perceptions about SIDS.
The study sample comprised a cross-section of African-American families
with infants from birth to age 6 months in Washington, DC, and
Maryland. The authors intentionally recruited families with a broad
range of socioeconomic status (SES) to ensure the widest possible range
of experiences, influences, and attitudes. The authors selected a
purposeful sample of parents, whom they predicted, from their survey
responses, would have wide-ranging attitudes and opinions to
participate in focus groups and individual interviews. The authors
conducted 13 focus groups and 10 individual interviews between July
2006 and December 2008; they asked questions specifically probing
parental beliefs and perceptions about SIDS. Data were organized,
sorted, and coded, and major themes were identified.
The authors found that
- The three major themes about understanding of SIDS were lack of
plausibility, randomness, and vigilance.
- Lack of plausibility: Many mothers did not understand the
connection between sleep position and SIDS and did not see this link as
being a plausible one. Several mothers did not understand how any risk
factors or protective factors could be defined for an entity that is
not explained. Furthermore, a number of mothers believed risk reduction
to be an absolute concept: you could either entirely eliminate the
risk, or you could not eliminate the risk at all.
- Randomness: Most mothers believed that SIDS occurs randomly and
that there was nothing one could do to decrease the risk.
- Vigilance. Mothers, particularly those in the lower-SES groups,
consistently believed that their own vigilance was the most important
factor in preventing SIDS. Sleep position, sleep location, and other
sleep behaviors were considered irrelevant as long as the parent was
next to and closely watching the infant.
The authors conclude that "additional guidance should be provided
about roomsharing without bedsharing and other alternatives that will
allow parents to maintain vigilance without endangering the infant" and
that "if parents are to perceive [safe sleep] messages as being
credible and important, there needs to be consistency in the safe sleep
messages that are provided by health care professionals and other
sources of information for parents."
Moon RY, Oden BL, Joyner BL, et al. 2010. Qualitative analysis of
beliefs and perceptions about sudden infant death syndrome in
African-American mothers: Implications for safe sleep recommendations.
Journal of Pediatrics 157(1):92-97. Abstract available at http://www.jpeds.com/article/S0022-3476%2810%2900042-9/abstract
************************************************************
2. STUDY EXPLORES THE IMPACT OF MISCARRIAGE HISTORY ON PRENATAL
DISTRESS DURING A SUBSEQUENT PREGNANCY
"Women with prior miscarriage had higher state anxiety in the second
and third trimesters of pregnancy when compared to women without prior
miscarriage," according to the authors of an article published (ahead
of print) in Research in Nursing and Health on June 11, 2010.
Approximately 20 percent of pregnancies in the United States result in
miscarriage. As with other stressful events, the effects of miscarriage
vary considerably across individuals. For many women and their
partners, miscarriage is a tragic, complicated, and life-altering
experience. The study described in the article used a prospective
design to examine the influence of miscarriage history on patterns and
magnitude of maternal distress during pregnancy. The authors also
explored the interaction between miscarriage status and parity status
(living children or none) to determine whether having a living child
buffers distress in women with a history of miscarriage.
Participants (N=363) were part of a larger longitudinal study of
psychosocial variables in pregnancy that included clients of a prenatal
care facility in a large, university-affiliated medical center located
in the northeastern region of the United States. Eligibility for the
larger study required participants to be at least 9 weeks' gestation at
recruitment, to be age 18 or older, and to speak English fluently. The
larger study was designed to include three interviews with women during
pregnancy. Data were collected in the clinic setting from 1995 to 2000.
Measures included history of prior miscarriage (self-reported),
demographics (including self-reported parity status), and distress
(total state anxiety and pregnancy-specific). Outcomes were modeled
according to gestational age, categorized into trimester.
Women with a prior history of miscarriage were older and less likely to
be currently employed and had lower total household incomes compared to
women without a history of miscarriage. Controlling for age, current
employment status, and income, the authors found that
- Distress (state anxiety and pregnancy-specific) varied across the
three trimesters, with values highest in the first trimester in both
groups, then decreasing in the second and third trimesters.
- Women who had a prior miscarriage had higher state anxiety in the
second and third trimesters than women without prior miscarriage, but
there was no statistically significant difference in the first
trimester.
- There was no significant effect of miscarriage history on
pregnancy-specific distress in early, mid-, or late pregnancy.
- Having a living child lowered anxiety overall in women without
prior miscarriage. The effect was consistent across the three
trimesters and was not seen in women with prior miscarriage.
"Results of our study demonstrate that including methodological
strengths such as controls for covariates and assessment of multiple
types of distress at multiple time points during pregnancy provides
important information about patterns and levels of distress in women
who experience pregnancy subsequent to miscarriage," state the authors.
They suggest that "future researchers could investigate the potential
benefits of supportive interventions implemented during subsequent
pregnancy, and particularly at mid- and late pregnancy, when women with
prior miscarriage in this study were found to have higher distress
compared to women with no prior miscarriage."
Woods-Giscombé CL, Lobel M, Crandell JL. 2010. The impact of
miscarriage and parity on patterns of maternal distress in pregnancy.
Research in Nursing and Health [published online ahead of print on June
11, 2010]. Abstract available at http://www3.interscience.wiley.com/journal/123513842/abstract
Readers: More information is available from the National Sudden and
Unexpected Infant/Child Death and Pregnancy Loss Resource Center at
Georgetown University as follows:
- Pregnancy Loss, Miscarriage, Stillbirth at
http://www.sidscenter.org/AZtopics/M.html#m7
Information is also available from the following MCH Library resource:
- Depression During and After Pregnancy: Knowledge Path at
http://mchlibrary.info/KnowledgePaths/kp_postpartum.html
************************************************************
3. AUTHORS ANALYZE PERCENTAGE OF INFANT MORBIDITY AND MORTALITY
ATTRIBUTABLE TO PRENATAL SMOKING
"Prenatal smoking continues to contribute to a substantial proportion
of avoidable cases of infant morbidity and mortality in the U.S.,"
write the authors of an article published in the July 2010 issue of the
American Journal of Preventive Medicine. Although smoking during
pregnancy declined from 18.1 percent in 1991 to 11.4 percent in 2002,
it remains one of the most prevalent and preventable causes of infant
morbidity and mortality in the United States. Two previous studies
found that between 5 and 6 percent of all infant deaths in the period
1995-1997 were caused by prenatal smoking, but these studies combined
all types of infant deaths, including those unrelated to prenatal
smoking (e.g., infant drowning). Using the most recent and complete
U.S. vital statistics data on prenatal smoking, this study provides
updated estimates of the percentages of poor pregnancy outcomes and
infant deaths attributable to prenatal smoking.
In 2009, the authors analyzed data from the U.S. Linked Birth/Infant
Death data set, 2002 birth cohort, which includes all births in the
United States in 2002, and linked infant death certificates occurring
among those live births. The authors estimated associations between
prenatal smoking and the following birth outcomes: preterm delivery,
term low birthweight (<2,500 g) deliveries, sudden infant death
syndrome (SIDS), and preterm-related deaths. The data set comprised
3,352,756 live births.
The authors found that
- Over 11.5 percent of singleton, live infants born in 2002 were
exposed to prenatal smoking (n=386,262). Compared with women who did
not smoke, women who smoked during pregnancy were more likely to be
younger, unmarried, less educated, and non-Hispanic white and to have
had three or more previous live births, to have initiated prenatal care
after the first trimester, and to have had low or high weight gain
during pregnancy.
- Prenatal smoking was associated with very-, moderate-, and
late-preterm deliveries and term low-birthweight deliveries, compared
to term greater than or equal to 2,500 deliveries.
- Prenatal smoking was associated with SIDS and preterm-related
deaths.
- A dose response of daily average cigarettes smoked was found for
all poor birth and infant death outcomes, and smoking at least 21
cigarettes each day had the strongest association with poor pregnancy
and infant outcomes.
- The fraction of adverse birth outcomes attributable to prenatal
smoking was 5.3 percent to 7.7 percent for very preterm deliveries, 4.6
percent to 6.7 percent for moderate preterm deliveries, and 2.6 percent
to 3.7 percent for late preterm deliveries.
- The fraction of term low-birthweight deliveries attributable to
prenatal smoking was 13.1 percent to 19.0 percent.
- The fraction of preterm-related deaths attributable to prenatal
smoking was 5.0 percent to 7.3 percent, and the fraction of SIDS deaths
attributable to prenatal smoking was 23.2 percent to 33.6 percent.
- The fraction of all infant deaths attributable to prenatal
smoking was 2.8 percent to 4.1 percent.
The authors conclude that "prenatal smoking prevalence is decreasing;
however, in some states prenatal smoking prevalence is as high as 36
percent, more than three times the national average." They continue,
"maternal and child healthcare providers need to work in concert with
state tobacco control professionals to improve access to comprehensive
insurance coverage [for tobacco-dependence treatment programs] and to
strengthen state tobacco control policies to reduce prenatal smoking
rates and prevent the harm smoking causes to both mother and child."
Dietz PM, England L, Shapiro-Mendoza CK, et al. 2010. Infant morbidity
and mortality attributable to prenatal smoking in the U.S. American
Journal of Preventive Medicine 39(1):45-52. Abstract available at http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VHT-50937JG-5&_user=10&_coverDate=07%2F31%2F2010&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0aa0db2917a7c7c0063ec733e4660f66
************************************************************
4. RESEARCH INVESTIGATES ASSOCIATION BETWEEN EXPOSURE TO VALPROIC ACID
IN
PREGNANCY AND RISK OF MAJOR CONGENITAL MALFORMATION
"We found that exposure to valproic acid during the first trimester [of
pregnancy] was associated with increased risks of six specific
[congenital] malformations, as compared with no exposure to
antiepileptic drugs, and the risks of five of these six malformations
remained significantly increased when we compared valproic acid
exposure with exposure to other antiepileptic drugs," state the authors
of an article published in the June 10, 2010, issue of the New England
Journal of Medicine. Valproic acid, which has been used for the
treatment of seizures for more than 30 years, has long been recognized
as a teratogen. Recently, the American Academy of Neurology recommended
avoidance of valproic acid during pregnancy if possible. The article
describes findings from an analysis of cohort studies of women exposed
to valproic acid in pregnancy and a population-based, case-control
study to detect excess risks of specific malformations.
The population-based, case-control study used the antiepileptic-study
database established by the European Surveillance of Congenital
Anomalies (EUROCAT). The EUROCAT included data on affected live births,
stillbirths, fetal deaths after 20 or more weeks of gestation, and
terminations of pregnancy after prenatal diagnosis for the years 1995
through 2005 from 19 population-based registries in 14 countries. Data
recorded for each registration (pregnancy outcomes with malformations)
included standard EUROCAT malformation subgroups; maternal illness
before and during pregnancy; and maternal antiepileptic drug exposure
in the first trimester of pregnancy. The review of published cohort
studies identified 14 major congenital malformations for which the risk
appeared to be significantly increased in association with exposure to
valproic acid monotherapy during the first trimester of pregnancy as
compared with no exposure to antiepileptic drugs during the first
trimester. The analyses compared the odds of exposure to valproic acid
monotherapy among cases (all live births, fetal deaths after at least
20 weeks of gestation, and terminations of pregnancy after prenatal
diagnosis with at least one of 14 malformations identified from the
literature review) with the odds of exposure in two groups of controls:
(1) a group with major malformations other than those under study and
(2) a group with malformations associated with chromosomal
abnormalities. Exposure to valproic acid monotherapy during the first
trimester was compared with the absence of exposure to antiepileptic
drugs and with exposure to an antiepileptic-drug monotherapy other than
valproic acid.
The authors found that
- The frequency of exposure to valproic acid was three times as
high among cases as among controls in both groups.
- In analyses of cases and controls in group 1, exposure to
valproic acid monotherapy during the first trimester compared with no
exposure to antiepileptic drugs during that period was associated with
significant increases in the risks of spina bifida, atrial septal
defect, cleft palate, hypospadias, polydactyly, and craniosynostosis.
- There were generally similar associations between valproic acid
exposure and malformations when valproic acid monotherapy was compared
with monotherapy with another antiepileptic drug -- with two
exceptions: valproic acid use was not associated with a significantly
increased risk of craniosynostosis but was associated with a
significantly increased risk of ventricular septal defect.
- In analyses comparing cases with controls in group 2 (those with
chromosomal abnormalities), the results were generally similar.
- Separate analyses of the suggested association between valproic
acid exposure and limb reduction showed a significantly increased risk
of limb reduction compared with the absence of exposure to
antiepileptic drugs.
"These findings support a relationship of these malformations to
valproic acid specifically rather than to antiepileptic drugs generally
or to underlying epilepsy," conclude the authors, adding that "the
risks associated with valproic acid use should be routinely considered
in choosing therapy for women with childbearing potential."
Jentink J, Loane MA, Dolk H, et al. 2010. Valproic acid monotherapy in
pregnancy and major congenital malformations. New England Journal of
Medicine 362(23):2185-2193. Abstract available at http://content.nejm.org/cgi/content/abstract/362/23/2185
Readers: More information is available from the following MCH Library
resource:
- Preconception and Pregnancy: Knowledge Path at
http://mchlibrary.info/KnowledgePaths/kp_pregnancy.html
************************************************************
To subscribe to MCH Alert, send an e-mail message to MCHAlert-request@lists.mchgroup.org with SUBSCRIBE in the subject line. You do not need to enter any text
in the body of the message.
To unsubscribe from MCH Alert, send an e-mail message to MCHAlert-request@lists.mchgroup.org with UNSUBSCRIBE in the subject line. You do not need to enter any text
in the body of the message.
************************************************************
MCH Library shares notices of new issues of MCH Alert on Twitter at http://bit.ly/OKv5Y
************************************************************
MCH Alert © 1998-2010 by National Center for Education in Maternal
and
Child Health and Georgetown University. MCH Alert: Focus on Infant
Mortality is produced by
Maternal and Child Health Library at the National Center for Education
in Maternal and Child Health at Georgetown University under its
cooperative agreements
(U02MC00001 and U48MC08717) with the Maternal and Child Health Bureau,
Health
Resources and Services Administration, U.S. Department of Health and
Human Services. The Maternal and Child Health Bureau reserves a
royalty-free, nonexclusive, and irrevocable right to use the work for
federal purposes and to authorize others to use the work for federal
purposes.
Permission is given to forward MCH Alert, in its entirety, to others.
For
all other uses, requests for permission to duplicate and use all or
part of the information contained in this publication should be sent to mchalert@ncemch.org.
The editors welcome your submissions, suggestions, and questions.
Please contact us at the address below.
EDITOR/ADMINISTRATOR: Jolene Bertness, M.Ed.
CO-EDITOR: Tracy Lopez, M.S.L.S.
COPYEDITOR/WRITER: Ruth Barzel, M.A.
WRITER: Beth DeFrancis, M.L.S.
MCH Alert
Maternal and Child Health Library
National Center for Education in Maternal and Child Health
Georgetown University
Box 571272
Washington, DC 20057-1272
Phone: (202) 784-9770
Fax: (202) 784-9777
E-mail: mchalert@ncemch.org
Web site: http://www.mchlibrary.info/alert
************************************************************